Literature DB >> 3128998

Prevalence and risk factors of HIV infections among drug users and drug-using prostitutes in Amsterdam.

J A van den Hoek1, R A Coutinho, H J van Haastrecht, A W van Zadelhoff, J Goudsmit.   

Abstract

In December 1985 we started a study to determine the prevalence and risk factors of HIV infection among drug users and drug-using prostitutes in Amsterdam. Recruitment took place at methadone posts (not drug-free; i.e. a low-threshold programme on which some drug users continue to use hard drugs, but at a lower level) and the weekly evening sexually transmitted diseases (STD) clinic for drug-addicted prostitutes. Three hundred and ten drug users have so far been tested and interviewed. Eighty-one per cent reported intravenous drug use; 83% of the 166 females and 15% of the 144 men reported prostitution. Female prostitutes practised mainly vaginal and orogenital intercourse and reported frequent use of condoms (89% of vaginal and 64% of orogenital contact). Male prostitutes practised mainly orogenital and manual contact. At entry 88 of the 310 (28%) were HIV-antibody-seropositive; 85 of these 88 were intravenous drug users and three were male homosexuals. HIV-antigen was detected in two seropositive and one seronegative intravenous drug-user. Antibodies to HTLV-I were found in four out of 308. Risk factors independently associated with HIV-antibody seropositivity among intravenous drug users were: frequency of borrowing used needle or syringe, date of first intravenous drug use, recent intravenous drug use, time living in Amsterdam and German nationality. Of medical history data, an attack of herpes zoster in the previous 5 years had the greatest value in the prediction of the presence of HIV antibodies (relative risk 20.90; 95% confidence interval 2.41-167.27).(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Year:  1988        PMID: 3128998     DOI: 10.1097/00002030-198802000-00010

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  51 in total

1.  Knowledge of HIV serostatus and preventive behaviour among European injecting drug users: second study. European Community Study Group on HIV in Injecting Drug Users.

Authors:  M G Schlumberger; J C Desenclos; G Papaevangelou; S C Richardson; R Ancelle-Park
Journal:  Eur J Epidemiol       Date:  1999-03       Impact factor: 8.082

2.  Methadone treatment by general practitioners in Amsterdam.

Authors:  G van Brussel
Journal:  Bull N Y Acad Med       Date:  1995

Review 3.  The social course of drug injection and sexual activity among YMSM and other high-risk youth: an agenda for future research.

Authors:  Michael C Clatts; Lloyd Goldsamt; Alan Neaigus; Dorinda L Welle
Journal:  J Urban Health       Date:  2003-12       Impact factor: 3.671

4.  Needle sharing and participation in the Amsterdam Syringe Exchange program among HIV-seronegative injecting drug users.

Authors:  C Hartgers; E J van Ameijden; J A van den Hoek; R A Coutinho
Journal:  Public Health Rep       Date:  1992 Nov-Dec       Impact factor: 2.792

5.  HIV prevalence and risk behavior among injecting drug users who participate in "low-threshold" methadone programs in Amsterdam.

Authors:  C Hartgers; A van den Hoek; P Krijnen; R A Coutinho
Journal:  Am J Public Health       Date:  1992-04       Impact factor: 9.308

6.  Estimating the size of the HIV epidemic among injecting drug users in Amsterdam.

Authors:  H J van Haastrecht; P J Bindels; A A van den Hoek; R A Coutinho
Journal:  Eur J Epidemiol       Date:  1997-04       Impact factor: 8.082

7.  An assessment of factorial structure and health-related quality of life in problem drug users using the Short Form 36 Health Survey.

Authors:  Angela Buchholz; Anneke Krol; Fred Rist; Pythia T Nieuwkerk; Gerard M Schippers
Journal:  Qual Life Res       Date:  2008-07-12       Impact factor: 4.147

Review 8.  STD control in drug users and street youth.

Authors:  A van den Hoek
Journal:  Genitourin Med       Date:  1997-08

9.  Injecting risk behavior among drug users in Amsterdam, 1986 to 1992, and its relationship to AIDS prevention programs.

Authors:  E J van Ameijden; A R van den Hoek; R A Coutinho
Journal:  Am J Public Health       Date:  1994-02       Impact factor: 9.308

10.  Major decline of hepatitis C virus incidence rate over two decades in a cohort of drug users.

Authors:  Charlotte H S B van den Berg; Colette Smit; Margreet Bakker; Ronald B Geskus; Ben Berkhout; Suzanne Jurriaans; Roel A Coutinho; Katja C Wolthers; Maria Prins
Journal:  Eur J Epidemiol       Date:  2007-03-03       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.